lisocabtagene maraleucel
bms
['transcend,(-nhl-001),(-nhl 001),(-nhl001),(-nhl-006),(-nhl 006),(-nhl006),(-pilot-017006),(-pilot017006),(-pilot 017006)', 'lisocel']
transcend lisocel mcl
efficacy data 12mo pfs 53%
18mo pfs 44% orr 83%
crr 72% is there a tail to that curve? hard to say yet #17icml #icml2023 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem